News & Perspective

Mar 08, 2019

Mar 08, 2019

ASP Scan (Weekly) for Mar 08, 2019

Home therapy for kids' cellulitis
Antibiotics and UTI relapse
Outpatient surgery overprescribing
Resistance prevalence and sepsis
Resistant gonorrhea strain
Empiric antibiotics and UTI
Surgery-linked resistant Pseudomonas
Preventing healthcare-related infection
Resistance and sustainable development
New CARB-X funding
ESBL prediction models

Jan 11, 2019

Jan 11, 2019

ASP Scan (Weekly) for Jan 11, 2019

US XDR typhoid cases
ICU Klebsiella stewardship
Antimicrobials in European chickens
MCR-1 in Wyoming
CDC alert over Mexico infections
Highly resistant gonorrhea in the UK
Penicillin allergy testing
Antibiotics and joint replacement
MDR Shigella in Australia
Resistant-infection alert in RI

Aug 09, 2016

Aug 09, 2016

News Scan for Aug 09, 2016

Aerosol stability in Ebola
HIV and drug-resistant TB
Global flu status
Campylobacter infection in children
Chikungunya update

Jun 28, 2016

Jun 28, 2016

News Scan for Jun 28, 2016

Saudi MERS cases
2009 H1N1 origins in Mexico
WHO health emergency head
Strategic National Stockpile report

Jul 31, 2015

Jul 31, 2015

News Scan for Jul 31, 2015

Cyclospora goes nationwide
Avian flu in Nigeria, UK
Flu in live-animal markets
CSL-Novartis deal

May 12, 2015

May 12, 2015

News Scan for May 12, 2015

Pertussis prevention
Public health R & D
Avian influenza outbreaks

Feb 05, 2013

Feb 05, 2013

NIH launches trio of trials seeking better flu treatments

(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»